FN1 and acute myeloid leukemia: Primary AML had a higher viability when incubated on BMSC or fibronectin (Figure 3E and 3F) compared to uncoated plates in the presence of daunorubicin 0.1μM (DNR) and cytarabine 0.5μM (ARA-c), both of which are conventional chemotherapeutic agents used in AML.